Literature DB >> 18263732

GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.

Jane E Lauckner1, Jill B Jensen, Huei-Ying Chen, Hui-Chen Lu, Bertil Hille, Ken Mackie.   

Abstract

The CB(1) cannabinoid receptor mediates many of the psychoactive effects of Delta(9)THC, the principal active component of cannabis. However, ample evidence suggests that additional non-CB(1)/CB(2) receptors may contribute to the behavioral, vascular, and immunological actions of Delta(9)THC and endogenous cannabinoids. Here, we provide further evidence that GPR55, a G protein-coupled receptor, is a cannabinoid receptor. GPR55 is highly expressed in large dorsal root ganglion neurons and, upon activation by various cannabinoids (Delta(9)THC, the anandamide analog methanandamide, and JWH015) increases intracellular calcium in these neurons. Examination of its signaling pathway in HEK293 cells transiently expressing GPR55 found the calcium increase to involve G(q), G(12), RhoA, actin, phospholipase C, and calcium release from IP(3)R-gated stores. GPR55 activation also inhibits M current. These results establish GPR55 as a cannabinoid receptor with signaling distinct from CB(1) and CB(2).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18263732      PMCID: PMC2268199          DOI: 10.1073/pnas.0711278105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  33 in total

1.  Reconstitution of muscarinic modulation of the KCNQ2/KCNQ3 K(+) channels that underlie the neuronal M current.

Authors:  M S Shapiro; J P Roche; E J Kaftan; H Cruzblanca; K Mackie; B Hille
Journal:  J Neurosci       Date:  2000-03-01       Impact factor: 6.167

2.  PIP(2) activates KCNQ channels, and its hydrolysis underlies receptor-mediated inhibition of M currents.

Authors:  Hailin Zhang; Liviu C Craciun; Tooraj Mirshahi; Tibor Rohács; Coeli M B Lopes; Taihao Jin; Diomedes E Logothetis
Journal:  Neuron       Date:  2003-03-27       Impact factor: 17.173

3.  Alpha-thrombin-mediated phosphatidylinositol 3-kinase activation through release of Gbetagamma dimers from Galphaq and Galphai2.

Authors:  Reema Goel; Polly J Phillips-Mason; Alice Gardner; Daniel M Raben; Joseph J Baldassare
Journal:  J Biol Chem       Date:  2003-12-09       Impact factor: 5.157

4.  Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum.

Authors:  Anatol C Kreitzer; Adam G Carter; Wade G Regehr
Journal:  Neuron       Date:  2002-05-30       Impact factor: 17.173

5.  Activation of mitogen-activated protein kinases by stimulation of the central cannabinoid receptor CB1.

Authors:  M Bouaboula; C Poinot-Chazel; B Bourrié; X Canat; B Calandra; M Rinaldi-Carmona; G Le Fur; P Casellas
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

6.  Structure of a cannabinoid receptor and functional expression of the cloned cDNA.

Authors:  L A Matsuda; S J Lolait; M J Brownstein; A C Young; T I Bonner
Journal:  Nature       Date:  1990-08-09       Impact factor: 49.962

7.  Cannabinoids activate an inwardly rectifying potassium conductance and inhibit Q-type calcium currents in AtT20 cells transfected with rat brain cannabinoid receptor.

Authors:  K Mackie; Y Lai; R Westenbroek; R Mitchell
Journal:  J Neurosci       Date:  1995-10       Impact factor: 6.167

8.  Molecular characterization of a peripheral receptor for cannabinoids.

Authors:  S Munro; K L Thomas; M Abu-Shaar
Journal:  Nature       Date:  1993-09-02       Impact factor: 49.962

9.  Dynamics of calcium clearance in mouse pancreatic beta-cells.

Authors:  Liangyi Chen; Duk-Su Koh; Bertil Hille
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

Review 10.  Dantrolene--a review of its pharmacology, therapeutic use and new developments.

Authors:  T Krause; M U Gerbershagen; M Fiege; R Weisshorn; F Wappler
Journal:  Anaesthesia       Date:  2004-04       Impact factor: 6.955

View more
  244 in total

1.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

2.  Rehashing endocannabinoid antagonists: can we selectively target the periphery to safely treat obesity and type 2 diabetes?

Authors:  Mary-Elizabeth Patti
Journal:  J Clin Invest       Date:  2010-07-26       Impact factor: 14.808

3.  Pitfalls and solutions in assaying anandamide transport in cells.

Authors:  Sergio Oddi; Filomena Fezza; Giuseppina Catanzaro; Chiara De Simone; Mariangela Pucci; Daniele Piomelli; Alessandro Finazzi-Agrò; Mauro Maccarrone
Journal:  J Lipid Res       Date:  2010-05-06       Impact factor: 5.922

Review 4.  Cannabinoid CB1 receptor-interacting proteins: novel targets for central nervous system drug discovery?

Authors:  Tricia H Smith; Laura J Sim-Selley; Dana E Selley
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 5.  CB2: a cannabinoid receptor with an identity crisis.

Authors:  Brady K Atwood; Ken Mackie
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 6.  Pharmacological characterization of GPR55, a putative cannabinoid receptor.

Authors:  Haleli Sharir; Mary E Abood
Journal:  Pharmacol Ther       Date:  2010-03-16       Impact factor: 12.310

Review 7.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

8.  Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator.

Authors:  X Zhang; Y Maor; J F Wang; G Kunos; J E Groopman
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

9.  Alterations in the intrinsic burst activity of Purkinje neurons in offspring maternally exposed to the CB1 cannabinoid agonist WIN 55212-2.

Authors:  Mohammad Shabani; Amin Mahnam; Vahid Sheibani; Mahyar Janahmadi
Journal:  J Membr Biol       Date:  2013-11-12       Impact factor: 1.843

10.  THC Reduces Ki67-Immunoreactive Cells Derived from Human Primary Glioblastoma in a GPR55-Dependent Manner.

Authors:  Marc Richard Kolbe; Tim Hohmann; Urszula Hohmann; Chalid Ghadban; Ken Mackie; Christin Zöller; Julian Prell; Jörg Illert; Christian Strauss; Faramarz Dehghani
Journal:  Cancers (Basel)       Date:  2021-03-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.